• 1. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Comprehensive Overview of (S)-2-((tert-butoxycarbonyl)amino)-2-(1-methylcyclohexyl)acetic acid (CAS No. 951789-86-9)

(S)-2-((tert-butoxycarbonyl)amino)-2-(1-methylcyclohexyl)acetic acid is a specialized chiral compound widely utilized in pharmaceutical research and organic synthesis. With the CAS number 951789-86-9, this compound has garnered significant attention due to its unique structural features and potential applications in drug development. The presence of the tert-butoxycarbonyl (Boc) protecting group and the 1-methylcyclohexyl moiety makes it a valuable intermediate for synthesizing peptides and other bioactive molecules.

In recent years, the demand for chiral building blocks like (S)-2-((tert-butoxycarbonyl)amino)-2-(1-methylcyclohexyl)acetic acid has surged, driven by advancements in asymmetric synthesis and the growing focus on enantioselective drug design. Researchers and pharmaceutical companies are increasingly exploring its utility in creating novel therapeutics, particularly for central nervous system (CNS) disorders and metabolic diseases. The compound's high purity and stereochemical integrity are critical for ensuring the efficacy and safety of final drug products.

One of the most searched questions related to this compound is: "What is the role of Boc-protected amino acids in peptide synthesis?" The answer lies in the compound's ability to safeguard the amino group during complex reactions, enabling selective deprotection and subsequent coupling. This property is indispensable for constructing peptides with precise sequences, a technique pivotal in developing targeted therapies. Additionally, the 1-methylcyclohexyl group contributes to enhanced lipophilicity, which can improve membrane permeability—a hot topic in drug delivery optimization.

From an SEO perspective, keywords such as "Boc-amino acid derivatives", "chiral synthesis intermediates", and "CAS 951789-86-9 applications" are frequently queried by chemists and industry professionals. These terms reflect the compound's relevance in cutting-edge research, including proteomics and bioconjugation. Moreover, the rise of AI-driven drug discovery has further amplified interest in such building blocks, as they are often used to train machine learning models for predicting molecular interactions.

Another trending topic is the compound's potential in green chemistry. With sustainability becoming a priority, researchers are investigating eco-friendly synthesis routes for (S)-2-((tert-butoxycarbonyl)amino)-2-(1-methylcyclohexyl)acetic acid, minimizing waste and energy consumption. This aligns with global initiatives like the UN Sustainable Development Goals (SDGs), particularly Goal 12 (Responsible Consumption and Production).

In summary, (S)-2-((tert-butoxycarbonyl)amino)-2-(1-methylcyclohexyl)acetic acid (CAS No. 951789-86-9) is a versatile and high-value compound with broad applications in medicinal chemistry and beyond. Its unique structural attributes, combined with the growing demand for enantiopure intermediates, position it as a critical component in modern scientific innovation. Whether you're exploring peptide therapeutics or sustainable synthesis, this compound offers unparalleled opportunities for advancement.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)